Pediatric Acute Hematogenous Osteomyelitis

Matthew Street1, Rupesh Puna, Mark Huang

  • 1*Starship Children's Hospital †Department of Medicine, University of Auckland, Auckland, New Zealand.

Insights

Acute hematogenous osteomyelitis (AHO) in New Zealand children shows decreasing incidence but persistent overrepresentation of Maori and Pacific Islanders. Staphylococcus aureus remains the primary pathogen with low MRSA rates, suggesting flucloxacillin is effective for empiric treatment.

Area of Science:

  • Pediatric Orthopedics
  • Infectious Diseases
  • Epidemiology

Background:

  • Osteomyelitis presents a significant challenge in New Zealand's pediatric population.
  • This study examines acute hematogenous osteomyelitis (AHO) cases to identify trends and inform management.

Purpose of the Study:

  • To analyze trends in pediatric AHO in Auckland over a 10-year period.
  • To guide effective management strategies for AHO in the New Zealand context.

Main Methods:

  • Retrospective review of clinical records from two Auckland pediatric orthopedic departments (1997-2008).
  • Inclusion of 813 pediatric AHO cases.
  • Level IV-retrospective case series.

Main Results:

  • AHO incidence decreased over the decade (1:4000), with male predominance and overrepresentation of Maori and Pacific Islanders.
  • Staphylococcus aureus was the most common pathogen (low MRSA incidence at 2%).
  • Average antibiotic treatment was 44 days, 44% required surgery, yielding a 7% recurrence rate and 15% complication rate.

Conclusions:

  • AHO incidence remains high in New Zealand, particularly among Maori and Pacific Islanders.
  • Low MRSA rates support flucloxacillin as empiric treatment; S. aureus is the main pathogen.
  • Low relapse rates may be linked to longer antibiotic courses, though this increases complication risk. Prompt diagnosis and tailored treatment are key to minimizing severe outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
395
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
808
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
5